Episode 169: MSTranslate with Brett Drummond
RealTalk MS23 Nov 2020

Episode 169: MSTranslate with Brett Drummond

Joining me this week is Brett Drummond, a scientist in Australia who stepped away from his lab to develop an online resource designed to bridge the gap between the MS patient community and the MS research community. The result of his efforts is MSTranslate. We're talking about this excellent curated MS information resource, and Brett even shares some insights into the MS research that he finds particularly exciting. We're also talking about the research team that used human stem cells to create myelin-producing cells in a lab dish in just 3 weeks. We'll tell you what a University of Washington Rehabilitation Medicine research team learned when they surveyed people living with MS about their level of distress during the first surge of the COVID-19 pandemic. Wouldn't it be convenient if MS progression could be measured by analyzing how you type on your smartphone? We'll tell you about the study that asked that question. We'll also share new discoveries from the Avonex clinical trial that show MS-related brain atrophy can be predicted 10 years before it occurs. And as we approach Thanksgiving in the U.S., we're sharing the things that we're thankful for this year. We have a lot to talk about! Are you ready for RealTalk MS??!

Being thankful in 2020 :22

Myelin-producing cells created in a lab dish in 3 weeks 5:43

UW Rehabilitation Medicine surveyed people living with MS on their feelings of distress & risk perception in the early phase of the COVID-19 pandemic 6:57

Measuring MS progression by typing on your smartphone 9:06

Study shows neurofilament light chain level at the first MS episode predicts future brain atrophy 10:43

My interview with Brett Drummond 14:54

Share this episode 37:13

Donate to the National MS Society COVID-19 Response Fund 37:34

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/169

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

MSTranslate

STUDY: Generation of Oligodendrocytes and Establishment of an All-Human Myelinating Platform for Human Pluripotent Stem Cells

STUDY: Distress and Risk Perception in People Living With Multiple Sclerosis During the Early Phase of the COVID-19 Pandemic

STUDY: Early-Warning Signals for Disease Activity in Patients Diagnosed with Multiple Sclerosis Based on Keystroke Dynamics

STUDY: Association of Serum Neurofilament Light Levels with Long-Term Brain Atrophy in Patients With a First Multiple Sclerosis Episode

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 169
Guests: Brett Drummond

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSActivist, MSTranslate, RealTalkMS

Privacy Policy

Avsnitt(505)

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Welcome back to the third and final part of our coverage of the 2026 ACTRIMS Forum. This week's episode bridges the gap between groundbreaking clinical research and the nuanced reality of living with ...

23 Feb 35min

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Welcome back to Part Two of our coverage of the 2026 ACTRIMS Forum. This week, we shift our focus to emerging therapies and clinical insights that are re-shaping the future of MS care. From the latest...

16 Feb 44min

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Last week, over 1,400 scientists and clinicians gathered in San Diego, California, at the 2026 Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the A...

9 Feb 33min

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investig...

2 Feb 39min

Episode 439: Preventing MS with Dr. Bruce Bebo

Episode 439: Preventing MS with Dr. Bruce Bebo

The first coordinated global research strategy to prevent MS has been announced. This week, Dr. Bruce Bebo, the National MS Society's Executive Vice President and Chief Research & Medical Affairs Offi...

26 Jan 32min

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

One of the more confusing aspects of MS is that it can present differently from one person to the next. A research team at University College London may have uncovered a reason for that when they iden...

19 Jan 29min

Episode 437: Remembering David Mitchell

Episode 437: Remembering David Mitchell

I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medicati...

12 Jan 29min

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Scientists are expanding our understanding of MS at an unprecedented pace. This week, Dr. Leorah Freeman discusses why, as new discoveries and medications enter clinical practice, neurologists and MS ...

5 Jan 34min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-jossan-nina
inga-beiga-morsor
rss-vuxna-pa-latsas
angestpodden
johannes-hansen-podcast
not-fanny-anymore
rss-viktmedicinpodden
sexnoveller-deluxe
sova-med-dan-horning
sa-in-i-sjalen
rss-sjalsligt-avkladd
brottarbroder
alska-oss
tyngre-radio
rss-basta-livet
rss-fet-fakta-podcast
tyngre-traningssnack
sex-pa-riktigt-med-marika-smith